2017 May 10
Ritchie reflects on research underway in Myeloproliferative Neoplasms
Ellen K. Ritchie, M.D., discusses the landscape of myeloproliferative neoplasms (MPNs). Read more
2017 May 10
Leonard highlights agents, approaches in pipeline for hematologic malignancies
John Leonard, M.D., discusses precision medicine, immunotherapy, CAR-T, and other emerging therapies in hematology. Read more
2017 May 10
Double-hit and double-expressor lymphomas
Sarah Rutherford, M.D., discusses the classification and prevalence of double-hit and double-expressor lymphomas. Read more
2017 May 10
Treating AYA patients with Hodgkin Lymphoma
Lisa Giulino Roth, M.D., discusses treating adolescent and young adult patients with Hodgkin lymphoma. Read more
2017 May 10
Midostaurin approval brings new hope in AML
Gail Roboz, M.D., discusses new and emerging treatments for acute myeloid leukemia (AML). Read more
2017 May 09
Using big data to make big strides in medicine
Christopher Mason, Ph.D., explains how a new initiative funded by WorldQuant founder Igor Tulchinsky will help medical researchers make better predictions. Read more
2017 May 09
Classifying T-cell lymphomas
Jia Ruan, M.D., Ph.D., discusses the classification of T-cell lymphomas. Read more
2017 May 09
Next steps in myeloma include combo regimens and achieving MRD
Ruben Niesvizky, M.D., discusses some of the exciting changes that have occurred in the field of multiple myeloma. Read more
2017 May 09
A 'stronger, more holistic' impact
Olivier Elemento, Ph.D., is featured in an article about Cornell's NYC connections. Read more
2017 May 08
Two Weill winners of Pershing Square Sohn Prize
Juan Cubillos-Ruiz and Yimon Aye were among six scientists selected as prestigious Pershing Square Sohn Prize winners. Read more
2017 May 05
New Method Developed to More Accurately Model Colorectal Cancer
Researchers have long struggled to develop preclinical models of colorectal cancer in which the disease forms in the correct anatomical location. Now Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center... Read more
2017 May 05
Patient preferences with MCL treatment
Peter Martin, M.D., assistant professor of medicine, discusses preferences patients have for treatment of their mantle cell lymphoma (MCL). Read more
2017 May 05
Emergence of CAR T-cell therapy in hematologic cancers
John P. Leonard, M.D., discusses the emergence and potential of chimeric antigen receptor (CAR) T-cell therapy across hematologic malignancies. Read more
2017 May 05
New method developed to more accurately model colorectal cancer
Using stem cells and three-dimensional organoids, Lukas Dow, Ph.D., and colleagues have created a colon cancer model that more accurately reflects the progression of the disease. Read more
2017 May 05
Pioneering program teaches students how to commercialize medical technologies
Graduate student Neel Madhukar came in second place in an entrepreneurship competition for medical technologies. Read more
2017 May 05
Collaborative startup will monitor pathogens in hospital settings
Feature about Biotia, a startup offering microbial surveillance for hospitals, is a joint venture between Christopher Mason and colleagues at Cornell Tech. Read more
2017 May 02
Delaying starting age for mammography won’t reduce overdiagnoses
A survey of almost six million breast exams found not one case of untreated cancer had regressed by the next mammogram—refuting the notion that overdiagnosis could be reduced by delaying the starting age for mammography screening or increasing the interval between exams. Read more
2017 May 02
Ongoing studies in the neoadjuvant setting for RCC
David M. Nanus, M.D., discusses ongoing studies in the neoadjuvant setting for patients with renal cell carcinoma (RCC). Read more
2017 May 02
The difference in treatment of left- and right-sided tumors in CRC
Manish A. Shah, M.D., discusses the difference in treatment of left- and right-sided tumors in colorectal cancer (CRC). Read more
2017 May 01
Needle in a Haystack
Video series follows Gail Roboz, Monica Guzman, Duane Hassane and the leukemia team as they tackle AML. Read more
